Florence Benhassine-Guivel
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Complement augments antibody neutralization of SARS-CoV-2 variants.
Journal: Science translational medicine
Published: July 22, 2026
Stealth replication of SARS-CoV-2 Omicron in the nasal epithelium at physiological temperature.
Journal: Journal of virology
Published: December 19, 2025
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153.
Journal: Science translational medicine
Published: December 10, 2025
Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1.
Journal: Nature communications
Published: November 07, 2025
DNA-PK interacts with cyclic dinucleotides and inhibits type I interferon responses.
Journal: The Journal of experimental medicine
Published: September 01, 2025
Carbon emissions associated with antenatal testing for hepatitis B prophylaxis eligibility, the Gambia.
Journal: Bulletin of the World Health Organization
Published: July 21, 2025
Potent neutralization by antibodies targeting the MPXV A28 protein.
Journal: Nature communications
Published: June 25, 2025
Optimized pipeline for generating highly potent neutralizing Affitins: Application to SARS-CoV-2 spike protein.
Journal: International journal of biological macromolecules
Published: May 02, 2025
Antiviral activity of tecovirimat against monkeypox virus clades 1a, 1b, 2a, and 2b.
Journal: The Lancet. Infectious diseases
Published: December 19, 2024
SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts.
Journal: Journal of virology
Published: November 21, 2024
MECHANISMS OF TECOVIRIMAT ANTIVIRAL ACTIVITY AND POXVIRUS RESISTANCE.
Journal: Research square
Published: October 14, 2024
Last Updated: 09/26/2026